Microsoft says TypeScript 7, announced July 8, brings native Go performance to VS Code, Visual Studio and other editors.

A comparison of seven automotive requirements management platforms for 2026, evaluating Jama Connect, Visure, Codebeamer, Polarion, IBM DOORS, Valispace, and ReqView across ISO 26262 compliance, ...

OpenDDE is a preview release. CLI flags, input/output JSON fields, and released checkpoints may change between versions, and predictions are not guaranteed to be reproducible across releases. It is ...

Google has released A2UI v0.9, a framework-agnostic standard for AI agents to declare user interface intent across multiple ...

Spring AI 2.0 advances the Java framework for generative AI apps with a Spring Boot 4 baseline, cleaner agentic tooling, Model Context Protocol support and vendor-backed integrations including Azure ...

How event-driven data pipelines reduce latency, automate schema changes, and improve reliability across large-scale data ...

Parallels, a leading global provider in virtualization and end-user computing (EUC) solutions, today announced a significant update to Parallels RAS (Remote Application Server), introducing a new ...

Many proponents of American manufacturing talk about making cars domestically and helping the U.S. auto industry soar. In the case of Detroit-based drone startup Birdstop, that is literally the plan.

Minecraft master Shark uses an auto build mod to instantly create structures and test automation in Minecraft. Trump’s new reflecting pool liner cut with a razor, official reports Live updates: US ...

As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates. Originally launched ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Introducing the first in vivo data using RetroT, a first-in-class all-mRNA platform for stable gene delivery without viral components Demonstrating CREATE's leadership in in vivo immune cell ...